Session Overview:
This is the 2nd webinar on this topic. Please click here to view the wrap around programme for Tirzepatide LCS BSOP. Please note that the video is password protected and you need to contact Surrey Training Hub to obtain it.
Learning Outcomes:
Understand Dosing, Titration, and Patient Support
- Confidently initiate Tirzepatide: starting dose, titration schedule, injection technique, and storage.
- Advise patients on what to expect, how to use the injection pen, and when to escalate or refer.
Manage Safety and Side Effects Proactively
- Identify and manage common adverse effects (e.g., nausea, vomiting, constipation).
- Understand when to pause, stop, or refer (e.g., in case of pancreatitis symptoms or intolerance).
- Recognize contraindications such as a personal or family history of medullary thyroid carcinoma or MEN 2.
NHS England has published
Interim commissioning guidance for the implementation of
NICE TA1026 and
NICE funding variation for Tirzepatide (Mounjaro®) prescribing which describes management during the first three years of delivery within the NHS for weight management. The document details eligible patient cohorts, prioritisation strategy and phased implementation of Tirzepatide across specialist weight management services and primary care settings.
Click here to book: 29 September 2025 12.30 - 13.00.